| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.09B | 959.27M | 800.62M | 680.15M | 590.32M |
| Gross Profit | 774.09M | 692.05M | 538.60M | 413.61M | 410.35M |
| EBITDA | 24.04M | -8.87M | 37.75M | -248.23M | -222.31M |
| Net Income | 81.59M | 33.46M | 15.88M | -212.09M | -185.07M |
Balance Sheet | |||||
| Total Assets | 1.89B | 1.69B | 1.59B | 1.52B | 1.62B |
| Cash, Cash Equivalents and Short-Term Investments | 900.34M | 942.67M | 1.04B | 1.18B | 1.30B |
| Total Debt | 11.02M | 2.42M | 6.76M | 12.75M | 1.96M |
| Total Liabilities | 937.22M | 791.39M | 715.92M | 806.46M | 700.96M |
| Stockholders Equity | 957.28M | 903.27M | 869.66M | 712.31M | 923.39M |
Cash Flow | |||||
| Free Cash Flow | 135.62M | 90.23M | -43.16M | -162.45M | -99.83M |
| Operating Cash Flow | 151.23M | 91.30M | -42.05M | -159.12M | -90.73M |
| Investing Cash Flow | -267.45M | -378.56M | -65.69M | 519.93M | 364.26M |
| Financing Cash Flow | -35.49M | -7.88M | -7.43M | -7.18M | -27.84M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | HK$947.31M | 4.89 | 23.35% | 9.81% | 2.06% | 2.52% | |
64 Neutral | HK$3.74B | 10.86 | -8.12% | ― | 3.16% | ― | |
62 Neutral | HK$1.76B | 12.19 | 8.53% | ― | 14.29% | 142.01% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | HK$28.45B | 56.51 | 1.71% | ― | 12.11% | ― | |
44 Neutral | HK$4.15B | -77.28 | -1.00% | ― | 10.59% | 98.05% | |
42 Neutral | HK$5.82B | -8.17 | -66.11% | ― | 18.94% | 89.36% |